Missed GME or NVDA? Donโt Miss the Next One.โ
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Retractable Technologies Inc. (RVP) Stock Forecast & Price Prediction United States | NYSE | Healthcare | Medical Instruments & Supplies
$0.75
+0.00 (0.00%)10 Quality Stocks Worth Considering Now
Researching Retractable Technologies (RVP) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on RVP and similar high-potential opportunities.
RVP has shown a year-to-date change of 8.7% and a 1-year change of -26.5%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for RVP. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for RVP.
Date | Firm | Analyst | Rating | Change | Price Target |
---|
The following stocks are similar to Retractable Technologies based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Retractable Technologies Inc. has a market capitalization of $22.45M with a P/E ratio of 8.1x. The company generates $33.05M in trailing twelve-month revenue with a -36.0% profit margin.
Revenue growth is -36.5% quarter-over-quarter, while maintaining an operating margin of -79.6% and return on equity of -12.8%.
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Develops innovative safety medical devices.
The company generates revenue by designing, manufacturing, and marketing safety medical devices, primarily retractable and injection needle systems. These products are sold to hospitals, clinics, and medical facilities worldwide, focusing on enhancing safety in medical environments and reducing the risk of needle-stick injuries.
Retractable Technologies Inc. is committed to technological innovation and quality, which helps it influence best practices in medical device safety. The company's efforts contribute significantly to public health and safety, making it a crucial player in the healthcare industry.
Healthcare
Medical Instruments & Supplies
221
Mr. Thomas J. Shaw
United States
2001
Retractable Technologies, Inc. reported Q1 2025 net sales of $8.3 million and an operating loss of $4.7 million, up from $7.6 million in sales and a $3 million loss in Q1 2024, attributed to higher tariffs and production costs.
Retractable Technologies' rising sales yet increasing losses highlight challenges from tariffs and production costs, signaling potential financial strain and affecting investor sentiment.
Retractable Technologies, Inc. has reduced its workforce by 7%, aiming to save $1.6 million annually, despite incurring $300,000 in one-time separation payments.
Retractable Technologies' workforce reduction indicates cost-cutting measures, potentially improving profitability. However, one-time separation costs may impact short-term earnings.
Retractable Technologies, Inc. declared dividends of $39,050 for Series II Class B and $18,561.25 for Series III Class B Preferred Stock, covering Q1 2025, payable on April 21, 2025.
Retractable Technologies' dividend declaration signals financial stability and shareholder returns, potentially attracting income-focused investors and boosting stock demand.
Retractable Technologies, Inc. reported a 24.2% decrease in revenues for 2024, totaling approximately $33.0 million. Further details are in their Form 10-K filed on March 28, 2025.
A 24.2% revenue decline signals potential operational issues at Retractable Technologies, affecting profitability and investor confidence. This impacts stock performance and future outlook.
Retractable Technologies, Inc. has withdrawn its complaint regarding a 100% tariff on syringes and needles from China, leading to the case's dismissal as of January 8, 2025.
Retractable Technologies' withdrawal of the tariff complaint signals reduced regulatory risk, potentially stabilizing costs and improving profit margins, which can positively impact stock performance.
Retractable Technologies, Inc. reported Q3 2024 net sales of $10.3 million, unchanged from last year, with an operating loss of $5.1 million, up from a $936 thousand loss. Year-to-date sales are $24.0 million.
Retractable Technologies shows stagnant sales and increased operating losses, highlighting potential financial instability and challenges in profitability, which can influence investor confidence negatively.
Analyst forecasts for Retractable Technologies Inc. (RVP) are not currently available. The stock is trading at $0.75.
Analyst ratings for RVP are not currently available. The stock is currently trading at $0.75. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
Price predictions from Wall Street analysts for RVP are not currently available. The stock is trading at $0.75.
The company generates revenue by designing, manufacturing, and marketing safety medical devices, primarily retractable and injection needle systems. These products are sold to hospitals, clinics, and medical facilities worldwide, focusing on enhancing safety in medical environments and reducing the risk of needle-stick injuries.
Price targets from Wall Street analysts for RVP are not currently available. The stock is trading at $0.75.
Price targets from Wall Street analysts for RVP are not currently available. The stock is trading at $0.75.
Analyst ratings for RVP are not currently available. The stock is trading at $0.75.
Stock price projections, including those for Retractable Technologies Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.